Literature DB >> 3394513

Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain.

R Sorva1.   

Abstract

Pre- and postoperative growth was analyzed in 22 children with craniopharyngioma. In 19 children a growth failure preceded the diagnosis by a mean of 4 years. Six children were obese preoperatively. During the first 3 postoperative months relative weight increased greater than 10% in 14/21 children (there was one surgical death). One year after surgery 13/21 were obese. Neither the size of the tumor nor the mode of surgery was decisive in the development of the obesity. Serum insulin and insulin-like growth factor I (IGF-I) were assessed in four children with growth hormone deficiency (GHD) who, after surgery for craniopharyngioma, were growing normally without GH substitution. One of them was normal in weight and had normal insulin and IGF-I levels; the others were obese and had supranormal insulin and subnormal IGF-I levels. One of the four and two other children with unsubstituted GHD reached final height SDS -0.8, -2.0 and -2.4. One child with normal postoperative GH response reached final height SDS -0.7. Final height SDS greater than or equal to -2.5 was gained with GH substitution by 6/11 children. It was greater than 2.0 SD below the height SDS expected from the heights of the parents in 7/11. An adequate monitoring of children's growth would lead to earlier diagnosis and probably better outcome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3394513     DOI: 10.1111/j.1651-2227.1988.tb10705.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  15 in total

1.  Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery.

Authors:  Gabrielle Page-Wilson; Sharon L Wardlaw; Alexander G Khandji; Judith Korner
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 2.  Endocrine manifestations of craniopharyngioma.

Authors:  Isil Halac; Donald Zimmerman
Journal:  Childs Nerv Syst       Date:  2005-07-27       Impact factor: 1.475

3.  Childhood craniopharyngioma in Macedonia: incidence and outcome after subtotal resection and cranial irradiation.

Authors:  Zoran S Gucev; Dragan Danilovski; Velibor Tasic; Jovica Ugrinovski; Vesna Nastova; Aleksandra Jancevska; Marina Krstevska-Konstantinova; Nada Pop-Jordanova; Ilija Kirovski
Journal:  World J Pediatr       Date:  2010-12-30       Impact factor: 2.764

4.  Growth and endocrine sequelae of craniopharyngioma.

Authors:  C J DeVile; D B Grant; R D Hayward; R Stanhope
Journal:  Arch Dis Child       Date:  1996-08       Impact factor: 3.791

5.  Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery.

Authors:  Taninee Sahakitrungruang; Tippayakarn Klomchan; Vichit Supornsilchai; Suttipong Wacharasindhu
Journal:  Eur J Pediatr       Date:  2010-11-25       Impact factor: 3.183

6.  Acute presentation of craniopharyngioma in children and adults in a Danish national cohort.

Authors:  E H Nielsen; J O Jørgensen; P Bjerre; M Andersen; C Andersen; U Feldt-Rasmussen; L Poulsgaard; L Ø Kristensen; J Astrup; J Jørgensen; P Laurberg
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

7.  Hypothalamic obesity in patients with craniopharyngioma: profound changes of several weight regulatory circuits.

Authors:  Christian L Roth
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-14       Impact factor: 5.555

8.  Effects of methylphenidate on weight gain and food intake in hypothalamic obesity.

Authors:  Clinton Thomas Elfers; Christian Ludwig Roth
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-14       Impact factor: 5.555

9.  Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment.

Authors:  Robert H Lustig
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-03       Impact factor: 5.555

10.  Bariatric surgery in hypothalamic obesity.

Authors:  Nathan C Bingham; Susan R Rose; Thomas H Inge
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.